Tau pathology has also begun to accumulate in specific regions of the neocortex a few years before symptoms emerge, and its presence is strongly associated with clinically detectable cognitive impairments and the occurrence and progression of brain atrophy [32]. This evidence concerns the gene MAPT and Cognitive impairment.